首頁 > 市場調查報告書 > 通訊

人工智能生成式人工智慧

市場調查報告書

商品編碼

2084651

臨床試驗中的生成式人工智慧市場：按組件、部署方法、應用、最終用戶和地區分類

Generative AI in Clinical Trial Market, By Component, By Deployment, By Application, By End User, By Geography

出版日期: 2026年06月11日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，用於臨床試驗的生成式人工智慧市場規模估計為6.854億美元，預計到2033年將達到42.768億美元。預計從2026年到2033年，其複合年成長率將達到29.9%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	6.854億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	29.90%	預計金額（2033 年）	42.768億美元

臨床試驗領域的生成式人工智慧市場正在重新定義製藥業的研發和藥物開發平臺。生成式人工智慧利用機器學習 (ML) 和自然語言處理 (NLP) 功能來最佳化臨床試驗設計、受試者招募和篩選、產生合成數據並加速試驗過程，從而在整個臨床試驗生命週期中提高營運效率、數據準確性和合規性。

在不斷成長的需求以及對更短藥物研發週期和更高核准率的需求推動下，製藥和生物技術領域對生成式人工智慧的需求日益成長。生成式人工智慧在這些領域的應用實例包括方案最佳化、受試者分層、真實世界證據產生、預測分析和監管資訊文檔編制。

市場動態

全球臨床試驗領域生成式人工智慧市場的發展動力源自於藥物研發成本、複雜性和週期不斷增加。隨著生成式人工智慧的普及，製藥和生物技術公司正擴大採用該技術來最佳化試驗設計、加速受試者招募、預測治療結果並簡化數據分析流程。包括電子健康記錄 (EHR)、真實世界數據和數位健康數據在內的數據量不斷成長，進一步加速了人工智慧在臨床研究中的應用。

然而，生成式人工智慧在臨床試驗領域的市場成長受到許多因素的限制，例如資料隱私問題、人工智慧衍生洞察的法規核准以及部署先進人工智慧基礎設施的高昂成本。儘管如此，個人化醫療、分散式臨床試驗以及人工智慧驅動的病患監測等領域的強勁需求將為市場成長提供充足的機會。隨著臨床研究產業經歷數位化變革，生成式人工智慧將在提升臨床試驗的效率和效果方面發揮日益重要的作用。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數，對全球臨床試驗生成式人工智慧市場中的主要公司進行介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球臨床試驗生成式人工智慧市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球人工智慧驅動的臨床試驗市場所使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南部非洲
- 北非
- 中非

第9章競爭情勢

Medidata Solutions
Unlearn.ai
ConcertAI
Tempus AI
Phesi
AiCure
Lokavant
H1
TrialX
NetraMark Holdings Inc.

第10章分析師建議

機會分析
分析師意見
Coherent Opportunity Map (COM)

第11章參考文獻與分析方法

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI9615

Generative AI in Clinical Trial Market is estimated to be valued at USD 685.4 Mn in 2026 and is expected to reach USD 4,276.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 29.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 685.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	29.90%	2033 Value Projection:	USD 4,276.8 Mn

The market for generative AI in clinical trial is redefining research in pharma and its drug development pipeline. Generative AI is speeding up clinical trials by refining the clinical trial design, patient recruitment and selection, producing synthetic data, and accelerating trial processes using its ML and NLP functionalities, thus increasing operational efficiency, improving data accuracy, and ensuring regulatory compliance throughout the lifecycle of a clinical trial.

Due to increasing demand and the need for reduced drug development time and the number of approvals, the demand for generative AI has gone up throughout both pharmaceutical and biotech fields and the application for generative AI in the fields are protocol optimization, patient stratification, generation of real-world evidence, predictive analytics and the documentation of regulatory information.

Market Dynamics

The global generative AI in clinical trial market is driven by increasing cost, complexity, and time for drug development traditionally. With the proliferation of generative AI, the pharmaceutical and biotechnology companies have increasingly adapted to optimize trial designs, enhance patient enrollment, forecast the results of a treatment, and simplify the data analysis part. The growing volume of data, including electronic health records (EHRs), real-world evidence, and digital health data, further enable the use of AI in clinical research.

However, the growth of generative AI in clinical trial market is limited by factors such as data privacy concerns, regulatory approval of the AI derived insights, and a high implementation cost of sophisticated AI infrastructure. Nevertheless, burgeoning demand from personalized medicine, decentralized clinical trials, and AI-driven patient monitoring would bring ample opportunities for market growth. As the clinical research industry undergoes a digital revolution, generative AI will hold a growing place to boost the efficiency and effectiveness of clinical trials.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global generative AI in clinical trial market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medidata Solutions, Unlearn.ai, ConcertAI, Tempus AI, Phesi, AiCure, Lokavant, H1, TrialX, and NetraMark Holdings Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global generative AI in clinical trial market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global generative AI in clinical trial market

Market Segmentation

Component Insights (Revenue, USD Mn, 2021 - 2033)
Software Platforms
Services
Deployment Insights (Revenue, USD Mn, 2021 - 2033)
Cloud-Based
On-Premise
Appication Insights (Revenue, USD Mn, 2021 - 2033)
Regulatory Documentation and Medical Writing
Patient Recruitment and Enrollment
Clinical Data Management and Analytics
Protocol Design and Trial Planning
Pharmacovigilance and Safety Monitoring
Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Academic and Research Institutions
Healthcare Providers and Clinical Research Centers
Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Medidata Solutions
Unlearn.ai
ConcertAI
Tempus AI
Phesi
AiCure
Lokavant
H1
TrialX
NetraMark Holdings Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Generative AI in Clinical Trial Market, By Component
- Global Generative AI in Clinical Trial Market, By Deployment
- Global Generative AI in Clinical Trial Market, By Application
- Global Generative AI in Clinical Trial Market, By End User
- Global Generative AI in Clinical Trial Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Industry Trends

4. Global Generative AI in Clinical Trial Market, By Component, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Software Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Generative AI in Clinical Trial Market, By Deployment, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Generative AI in Clinical Trial Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Regulatory Documentation and Medical Writing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Patient Recruitment and Enrollment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Clinical Data Management and Analytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Protocol Design and Trial Planning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pharmacovigilance and Safety Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Generative AI in Clinical Trial Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Healthcare Providers and Clinical Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Generative AI in Clinical Trial Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Medidata Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Unlearn.ai
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ConcertAI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Tempus AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Phesi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AiCure
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lokavant
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
H1
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
TrialX
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NetraMark Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies